Oxidative stress and inflammatory process in patients with atrial fibrillation: The role of left atrium distension

International Journal of Cardiology

Volumn 136, Issue 3, 2009, Pages 258-262

  Tousoulis, Dimitris ^a   Zisimos, Kostas ^a   Antoniades, Charalambos ^a   Stefanadi, Elli ^a   Siasos, Gerasimos ^a   Tsioufis, Costas ^a   Papageorgiou, Nikos ^a   Vavouranakis, Emmanuil ^a   Vlachopoulos, Charalambos ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atrial fibrillation; Endothelial function; Inflammation; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; GELATINASE B; OXIDIZED LOW DENSITY LIPOPROTEIN;

AGE DISTRIBUTION; ARTICLE; BRACHIAL ARTERY; CHRONIC DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HEART ATRIA; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 9; MYOCARDIUM; OXIDATIVE STRESS; REGIONAL BLOOD FLOW;

EID: 68049112397     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.087     Document Type: Article

References (37)

1. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998) 2N-9N
2. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
3. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
4. Sata N., Hamada N., Horinouchi T., et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?. Jpn Heart J 45 (2004) 441-445
5. Gaudino M., Andreotti F., Zamparelli R., et al. The 2174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation 108 (2003) 195-199
6. Dernellis J., and Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 56 (2001) 375-380
7. Anderson J.L., Allen Maycock C.A., Lappe D.L., et al. Intermountain Heart Collaborative Study group. Frequency of elevation of C-reactive protein in atrial fibrillation. Am J Cardiol 94 (2004) 1255-1259
8. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
9. Young-Xu Y., Jabbour S., Goldberg R., et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 92 (2003) 1379-1383
10. Vermes E., Tardif J.C., Bourassa M.G., et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials. Circulation 107 (2003) 2926-2931
11. Kallergis E, Manios E, Kanoupakis E, et al. The role of the post cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart 2008;94(2):200-4.
12. Dhalla N.S., Temsah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 18 (2000) 655-673
13. Korantzopoulos P., and Galaris D. The protective role of vitamin C onendothelial dysfunction. J Clin Basic Cardiol 6 (2003) 3-6
14. Carnes C.A., Chung M.K., Nakayama T., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 89 (2001) e32-e38
15. Tousoulis D., Antoniades C., and Stefanadis C. Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques. Heart 91 (2005) 553-558
16. Mihm M.J., Yu F., Carnes C.A., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
17. Bruins P., te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery: post surgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
18. Maycock C.A.A., Lappé D.L., Crandall B.G., et al. Is atrial fibrillation an inflammatory disease reflected by elevated C-reactive protein?. J Am Coll Cardiol 41 Suppl. A (2003) 99A
19. Asselbergs F.W., Diercks G.F., van den Berg M.P., et al. C-reactive protein and microalbunminuria are associated with atrial fibrillation. J Am Coll Cardiol 41 (2003) 99A
20. Conway D.S.G., Buggins P., Hughes E., and Lip G.Y.H. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
21. Sanchez P.L., Pabon P., Moriñigo J.L., et al. Do baseline C-reactive protein levels predict the new-onset of atrial fibrillation in patients with acute coronary syndrome?. Eur Heart J 24 (2003) 509
22. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation. Am J Cardiol 94 (2004) 508-510
23. Mukherjee R., Herron A., Sa B., Lowry A., et al. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation. Am J Cardiol 97 (2006) 532-537
24. Nakano Y., Niida S., Dote K., et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coll Cardiol 43 (2004) 818-825
25. Min Wu, and Yu-Guang Li. The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats. Mol Cell Biochem 282 (2006) 141-146
26. Mach F., Schönbeck U., Fabunmi R., et al. T Lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L dependent mechanism: implications for tubule formation. Am J Pathol 154 (1999) 229-238
27. Hammwöhner M., Ittenson A., Dierkes J., et al. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med 232 (2007) 581-589
28. Kumagai K., Nakashima H., and Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 62 (2004) 105-111
29. Pedersen O.D., Bagger H., Kober L., and Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 100 (1999) 376-380
30. Loh S.H., Jin J.S., Tsai C.S., et al. Possible underlying mechanism for hydrogen peroxide-induced electromechanical suppression in human atrial myocardium. J Hypertens 91 (2003) 53-60
31. Abraham R.B., Matza M., Marmor S., et al. Electromechanical impairment of human auricle and rat myocardial strip subjected to exogenous oxidative stress. Eur J Cardiothorac Surg 23 (2003) 66-73
32. Carnes C.A., Nakayama H., Nakayama T., et al. Redox modulation of atrial calcium current and contractility: altered response to betaadrenergic stimulation. Heart Rhythm 2 (2005) S256
33. Dhalla N.S., and Temsah R.M. Sarcoplasmic reticulum and cardiac oxidative stress: an emerging target for heart disease. Expert Opin Ther Targets 5 (2001) 205-217
34. Kim Y.H., Lee J.H., Lim D.S., et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 35 (2003) 336-349
35. Lin P.H., Lee S.H., Su C.H., and Wei Y.H. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 35 (2003) 1310-1318
36. Wolin M., and Gupte S. Novel roles for Nox oxidases in cardiac arrhythmia and oxidized glutathione export in endothelial function. Circ Res 97 (2005) 612-614
37. Kim Y., Guzik T., Zhang Y., et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97 (2005) 629-636